BioTime Appoints New V.P. of Stem Cell Research
The biopharmaceutical and regenerative medicine company BioTime has announced the appointment of Dr. Walter Funk as Vice President of Stem Cell Research.
August 10, 2009
The biopharmaceutical and regenerative medicine company BioTime has announced the appointment of Dr. Walter Funk as Vice President of Stem Cell Research.
A new clinical trial at the University of Wisconsin at Madison is using mesenchymal stem cells in the treatment of patients with Type 1 diabetes.
Once again, the successful use of autologous adult stem cells for the treatment of animals is in the news.
Once again, autologous adult stem cell therapy is successfully used to treat man’s best friend.
Biotech giant Novartis agrees to pay $4 million to Opexa Therapeutics for its proprietary adult stem cell technology.
Scientists apply principles of proteomics to embryonic stem cells in order to learn more about cellular differentiation.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2024, Stem Cell Insitute Panama. All rights reserved.